# IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

> **NCT05255965** · — · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 310 (actual)

## Conditions studied

- Thymoma

## Interventions

- **DIAGNOSTIC_TEST:** level of IL-8+ initial T cells

## Key facts

- **NCT ID:** NCT05255965
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-02
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05255965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05255965, "IL-8+ naïve T Cells as a Biomarker for Thymoma Identification". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05255965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*